Related Deals
Related Parents
Related Issuers
by Anna Tkachenko
Jun 18, 2026 11:08 AM ET
***Corrected IPT PXD
Issuer | Term | Call | Coupon | Maturity | Size | Ranking | Type | Price | Spread | IPT-PXD |
|---|---|---|---|---|---|---|---|---|---|---|
Neopharmed Gentili | 7NC1 | 1y | E+325 | 29-Jun-33 | €890m (up from EUR425m) | Sr Sec | Floating | 100 | E+325 | -50 |
Reoffer: E+325 / 100
Launched: €890m @ E+325 at par (EUR465m upsize to refinance EUR450m 7.125% sr sec notes due 08-APR-2030 notes)
Price Talk: E+325-350, 0%, par
IPTs: High 3s, par
https://dealroadshow.com/e/NEO2026 (Access Code: NEO2026)
https://evercall.co/oacc/46099 (GIC Registration)